U.S. Pharmaceuticals
U.S. Pharmaceuticals is a privately held specialty pharmaceutical company founded in 1954 that develops and distributes iron supplements, prenatal vitamins, probiotics, and cold/allergy products across more than 60,000 U.S. retail pharmacies and direct-to-consumer online channels.
- Company typePrivate
- Founded1954
- HeadquartersDecatur, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What U.S. Pharmaceuticals does
US Pharmaceutical Corporation (USPC, DBA USPC) is a privately held specialty pharmaceutical company founded in 1954 and headquartered in Decatur, Georgia. The company manufactures and distributes a focused branded portfolio of prescription and over-the-counter products across four therapeutic categories: iron supplements (Fusion, Integra, Tandem, and Hemocyte lines), prenatal vitamins (Provida OB and Concept lines), probiotics (Restora, Restora RX, Hylafem pH, and Calibra), and cold/allergy treatments (Norel AD). Its core technology rests on two proprietary platforms: Dual Action Technology, which is designed to replenish both ferritin (stored) and transferrin (circulating) iron pools and is protected under US Patent Application US20070077313, and the patent-protected Lactobacillus casei KE-99 probiotic strain, which has demonstrated resistance to gastric acids, bile, and pancreatic juice. Formulations also feature Vcaps vegetarian capsule technology with Kosher, Halal, and Vegetarian Society certifications.
The company monetizes through one-time product sales across an extensive U.S. distribution footprint of more than 60,000 retail pharmacies, supplemented by direct-to-consumer e-commerce through Amazon and a company-owned shop.uspco.com storefront. A field sales force engages healthcare providers with product literature, free samples, and downloadable pharmacy vouchers offering up to 80% savings, with pricing structured to meet many insurance deductibles. Additional channels include a specialized government and military ordering route. Customer segments span individual patients (iron deficiency patients, pregnant women, probiotic and cold/allergy users), prescribers (OB/GYNs, primary care), and pharmacy retailers, with patient education supported via brand-specific Facebook pages. The company is privately held, has not disclosed institutional funding, and currently employs 51-100 people.
U.S. Pharmaceuticals firmographics
Firmographics- Name
- U.S. Pharmaceuticals
- Legal name
- US Pharmaceutical Corporation
- Website
- https://uspco.com
- Company type
- Private
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- U.S. Pharmaceuticals is a privately held specialty pharmaceutical company founded in 1954 that develops and distributes iron supplements, prenatal vitamins, probiotics, and cold/allergy products across more than 60,000 U.S. retail pharmacies and direct-to-consumer online channels.
- Ownership category
- akta.pro rank
U.S. Pharmaceuticals industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Probiotics & Digestive Health Supplements (CRADAGAF), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Respiratory & Allergy Pharmaceuticals (HLAIAAAH)
Keywords
Where U.S. Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Decatur
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
U.S. Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Sale of prescription and OTC pharmaceutical products including iron supplements, prenatal vitamins, probiotics, and cold/allergy medications through retail pharmacies
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
U.S. Pharmaceuticals product offering
Product offeringCore offering
US Pharmaceutical Corporation manufactures and distributes a portfolio of prescription and OTC pharmaceutical products, primarily iron supplements (Fusion, Integra, Tandem, Hemocyte lines), prenatal vitamins (Provida OB, Concept), probiotics (Restora, Hylafem pH, Calibra), and cold/allergy treatments (Norel AD). The company leverages proprietary Dual Action Technology for iron repletion and a patent-protected Lactobacillus casei KE-99 probiotic strain, and sells its products through 60,000+ U.S. retail pharmacies, a direct healthcare provider sales force, online channels including Amazon, and government/military procurement.
Product overview
U.S. Pharmaceutical Corporation is a pharmaceutical company serving patients since 1954, offering a diversified portfolio of health products across four main categories: Iron Supplements (including Fusion, Integra, Tandem, and Hemocyte lines using proprietary Dual Action Iron Technology), Prenatal Vitamins (Provida OB and Concept lines with added probiotic and vitamin support), Probiotics (Restora oral and topical probiotic products featuring patent-protected Lactobacillus casei KE-99), and Cold/Allergy treatments (Norel AD). The company operates on a direct-to-consumer model with pharmacy vouchers, free samples for healthcare providers, and online purchasing through Amazon. Products are available in over 60,000 U.S. pharmacies and feature specialized capsule technologies (Vcaps) with Kosher, Halal, and Vegetarian certifications.
Differentiator
Problem solved
Functional benefit
Brands
- Fusion: Iron supplement line using Dual Action Technology to replete ferritin (stored) and transferrin (circulating) iron levels.
- Integra
- Tandem
- Hemocyte
- Provida
- Concept
- Restora
- Restora RX
- Calibra
- Hylafem pH
- Norel AD
Products and services
- Fusion™ Iron supplement line using Dual Action Technology that replenishes both ferritin (stored) and transferrin (circulating) iron levels, including Fusion Plus formulation, for patients requiring iron deficiency treatment.
- Integra Line Iron supplement line including Integra F, Integra Plus, and Integra formulations designed to replete iron levels in patients.
- Tandem® Ferrous Fumarate and Polysaccharide Iron Complex supplement capsules for iron supplementation, including the Tandem Plus variant.
- Hemocyte Line Iron supplement line including Hemocyte F and Hemocyte Plus formulations for iron deficiency and anemia treatment.
- Provida OB™ Prenatal multivitamin and mineral supplement enhanced with Lactobacillus casei KE-99 probiotic and Dual Action Iron technology, containing folic acid, vitamin C, vitamin D, and vitamin B6, with Kosher, Halal, and Vegetarian Society certifications.
- Concept Prenatal Line Prenatal vitamin line including Concept DHA and Concept OB formulations for prenatal nutritional support.
- Hylafem pH pH vaginal probiotic product providing a natural and alternative solution to vaginal infections.
- Restora™ Oral probiotic containing Lactobacillus casei KE-99 enhanced with Omega-3 for digestive flora restoration, featuring a patent-protected acid-resistant probiotic strain.
- Restora RX™ Nutritional supplement enhanced with Folic Acid and Lactobacillus casei KE-99 probiotic for increased digestive comfort, with an acid-resistant formula that does not require refrigeration.
- Calibra Topical Probiotic Topical probiotic skincare product marketed under the Calibra brand.
- Norel AD Cold, cough, and allergy medication containing Acetaminophen 325mg, Chlorpheniramine Maleate 4mg, and Phenylephrine HCl 10mg for symptomatic relief.
Quantifiable outcome
- Available in 60,000+ US pharmacies
Companies that use U.S. Pharmaceuticals
Customer profileSegments4 records
Ideal customer profiles4 records
U.S. Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
U.S. Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AmazonminorAmazon serves as an e-commerce platform for direct consumer sales of US Pharmaceutical Corporation products including Fusion, Integra, Tandem, Hemocyte, and Restora lines.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
U.S. Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Mission Pharmacal: Privately-held specialty pharmaceutical company with strong women's health and hematinic franchises (including CitraNatal prenatal vitamins). Comparable mid-size specialty pharma with HCP-driven sales model and similar focus on niche therapeutic categories.
- Duchesnay USA: Specialty pharma focused on women's health, particularly pregnancy-related treatments (Bonjesta, Diclectin for nausea). Direct overlap with USPC's prenatal vitamin franchise and similar HCP-targeted commercial model.
- Acella Pharmaceuticals: Smaller specialty pharmaceutical manufacturer with focus on niche categories including prenatal vitamins and hematinics. Closely comparable in scale and product mix to USPC.
- Upsher-Smith Laboratories: Mid-size specialty and generic pharmaceutical manufacturer with portfolio across women's health and chronic conditions. Comparable in operating model — privately-held, US-focused, with HCP and pharmacy distribution.
- Vertical Pharmaceuticals (formerly Ther-Rx): Specialty pharma focused on women's health with OB/GYN-targeted sales force. Direct overlap in prenatal and reproductive health categories with USPC's Provida and Concept lines.
- Pharmics Inc. Smaller specialty pharmaceutical company focused on hematinic/iron supplement products. Closely comparable niche competitor in the iron deficiency anemia treatment category.
- BioGaia: Global probiotic specialist with proprietary Lactobacillus strains used in dietary supplements. Comparable in probiotic platform strategy to USPC's KE-99-based Restora and Hylafem lines.
Broad incumbents
- Ferring Pharmaceuticals: Larger global specialty pharma with significant women's health and reproductive medicine franchise. Competes broadly in the same therapeutic categories but at materially greater scale and geographic reach.
- Endo International (Par Pharmaceutical): Large specialty/generic pharma with women's health and hematinic portfolio including prenatal vitamins. Overlaps with USPC in hematinic and women's health categories but operates at much larger scale.
Emerging players
- Bonafide Health: Direct-to-consumer women's health company with focus on perimenopause and menopause supplements. Emerging player in adjacent women's wellness categories that could expand into prenatal/nutrition segments overlapping with USPC.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks3 records
Key highlights7 records
Customer concentration
U.S. Pharmaceuticals social profiles
Digital presenceU.S. Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
U.S. Pharmaceuticals leadership team
Management profileNumber of profiles
U.S. Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
U.S. Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about U.S. Pharmaceuticals
What does U.S. Pharmaceuticals do?
US Pharmaceutical Corporation manufactures and distributes a portfolio of prescription and OTC pharmaceutical products, primarily iron supplements (Fusion, Integra, Tandem, Hemocyte lines), prenatal vitamins (Provida OB, Concept), probiotics (Restora, Hylafem pH, Calibra), and cold/allergy treatments (Norel AD). The company leverages proprietary Dual Action Technology for iron repletion and a patent-protected Lactobacillus casei KE-99 probiotic strain, and sells its products through 60,000+ U.S. retail pharmacies, a direct healthcare provider sales force, online channels including Amazon, and government/military procurement.
Is U.S. Pharmaceuticals a public or private company?
U.S. Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was U.S. Pharmaceuticals founded?
U.S. Pharmaceuticals was founded in 1954. It employs 51 to 100 people.
Where is U.S. Pharmaceuticals based?
U.S. Pharmaceuticals is headquartered in Decatur, United States, in the North America region.
How does U.S. Pharmaceuticals make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are U.S. Pharmaceuticals's main competitors?
Direct peers on record are Mission Pharmacal, Duchesnay USA, Acella Pharmaceuticals, Upsher-Smith Laboratories, Vertical Pharmaceuticals (formerly Ther-Rx), Pharmics Inc. and BioGaia. Broad incumbents are Ferring Pharmaceuticals and Endo International (Par Pharmaceutical). Bonafide Health is listed as an emerging player.
Does U.S. Pharmaceuticals have an API?
No public API is recorded for U.S. Pharmaceuticals.
What industry is U.S. Pharmaceuticals in?
U.S. Pharmaceuticals's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2834.